Health
AstraZeneca U.S. COVID-19 vaccine trial results likely in late-January, says health official – Reuters
AstraZeneca Plc will likely get results of its U.S. COVID-19 vaccine trial in late-January and could potentially file for an emergency authorization, the chief…
By Reuters Staff
FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange (NYSE) in New York, U.S., April 8, 2019. REUTERS/Brendan McDermid/File Photo
(Reuters) – AstraZeneca Plc will likely get results of its U.S. COVID-19 vaccine trial in late-January and could potentially file for an emergency authorization, the chief adviser for the U.S. governments Operation Warp Speed program said on Wednesday.
The British drugmaker…
-
Noosa News22 hours agoThis 42-Kilometre Walking Trail on the NSW North Coast Weaves Through Ancient Rainforest, Volcanic Mountains and Spectacular Waterfalls
-
General24 hours agoParents of Heidi, 3, remember ‘beautiful’ daughter killed in Ocean Grove crash
-
General24 hours agoNo ‘band-aid solution’: sweating coal risky business
-
Noosa News24 hours agoGabby Petito died after experiencing domestic violence. Young Aussies are identifying with her story